Careers  |  Sign In  |  Register

Latest in Oncology

Xiuning Le, MD, PhD, an assistant professor in the Department of Thoracic Head and Neck Medical Oncology, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, highlights positive results from the VISION clinical trial for non-small cell lung cancer (NSCLC). The VISION trial is...

PD-1 Immune Therapies May Leave Gap in Treatment of RCC

Dr. Braun on Unanswered Questions With PD-1 Blockade in Advanced RCC

David A. Braun, MD, PhD, physician at Dana-Farber Cancer Institute and instructor of medicine at Harvard Medical School, explains that while PD-1 blockade and immune therapies have been transformative for the treatment of renal cell carcinoma (RCC), not all patients respond to these standards of care. Kidney...

Prognosis of Patients with Central Nervous System Metastases from Melanoma

Dr. Glitza Olivia on the Prognosis of Melanoma Brain Metastases

Isabella C. Glitza Oliva, MD, PhD, MS, assistant professor in the Department of Melanoma Medical Oncology, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, discusses central nervous system (CNS) metastases from melanoma. Of all solid tumors, melanoma is most likely to...